(Date:7/25/2008)... reduces lung function, increases asthma risk, stu...hDay News) -- A clean, fresh-smelling home may act...pe of cleaning and air freshening products you use...leaning products or air fresheners that contain a ... dicholorobenzene (1,4 DCB), can reduce lung funct...
(Date:7/25/2008)... -- BeaconEquity.com announces the,availability of...tors can view all of the daily trading notes for f...ay,s Trade Alerts include: DUSA Pharmaceuticals In...nc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA),...asdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., ...
(Date:7/25/2008)...rketing Exclusivity Begins -, CORONA, Calif., Jul...als, Inc. (NYSE: WPI ), a leading specialty pharm...iary has commenced commercial,shipment of its Omep... 40mg,strength from its Davie, Florida manufacturi...n has 180 days of marketing exclusivity for being ...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3(Date:7/23/2008)...ound Pharmaceuticals (SPI) has filed,an Investigat...inical,testing of a proprietary formulation of ebs...aring loss or ototoxicity. The oral capsule,contai... stage lung cancer,and head and neck cancer patien...ks the second development program for SPI to enter...
(Date:7/23/2008)...Call/ -- Dendreon Corporation,(Nasdaq: DNDN ) tod...Monitoring Committee (IDMC) to review in October 2...ing to the Company,s Phase 3 IMPACT (IMmunotherapy... as D9902B) clinical trial,of PROVENGE(R) (sipuleu...active cellular immunotherapy for the treatment of...
(Date:7/22/2008)...evelopment Initiative bring MJFF,s,current active ...ry 20,2009, NEW YORK, July 22 /PRNewswire-USNews...of transformative treatments and a cure for Parkin...arkinson,s Research has awarded,$2.7 million in to...ards,were granted under MJFF,s Therapeutics Develo...
(Date:7/22/2008)...Importance to Patients of Passing a ..., Va., July 22 /- Insmed In...ogics and biopharmaceuticals, today,announced that...t at a,Congressional briefing on Friday, July 25th...shing an approval pathway for follow-on,biologics ...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 1Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 2Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 3EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 1EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 2EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 3EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 4Rand study examines the effect of policy on entrepreneurship and small businesses 8089 1Rand study examines the effect of policy on entrepreneurship and small businesses 8089 2Ames Laboratory researchers solve fuel cell membrane structure conundrum 2140 1Ames Laboratory researchers solve fuel cell membrane structure conundrum 2140 2...Genentech and FDA notified,healthcare professional...acheoesophageal (TE) fistula formation in a recent...ll cell lung,cancer (SCLC). This multicenter, non-...dy combined chemotherapy and radiation plus,Avasti...vents of TE,fistula (one fatal) reported in the fi...
...mence shortly, CARMIEL, Israel, April 18, 2007 /PR...Inc. today announced that it has received,written ...stration,(FDA) that it may initiate a Phase III cl...uct candidate, prGCD, a proprietary plant,cell exp...e (GCD),for the treatment of Gaucher Disease, a l...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time.
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric
By combining intra-operative ultrasound imaging with preoperative imagery, Medtronic Surgical Navigation Technologies has created a revolutionary product called SonoNav Intra-operative Imaging System
...oglue) is a two-component surgical adhesive compos...araldehyde. The BSA is obtained from cattle exclus...free countries and undergoes processing that reduc...nsed by a controlled delivery system, composed of ...
Medicine Products: